Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹16 Cr
P/E Ratio
--
P/B Ratio
-1.13
Industry P/E
36.67
Debt to Equity
-1.58
ROE
0 %
ROCE
-8.64 %
Div. Yield
0 %
Book Value
-14.56
EPS
-0.84
CFO
₹-1.47 Cr
EBITDA
₹-3.30 Cr
Net Profit
₹-19.96 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Norris Medicines
| 9.16 | 1.23 | -20.08 | 38.15 | -- | 47.41 | -- |
|
BSE Healthcare
| -5.48 | 1.35 | 0.22 | 22.74 | 20.05 | 23.06 | 9.77 |
|
BSE Small Cap
| -10.07 | 4.18 | -3.21 | 7.10 | 18.99 | 35.87 | 15.84 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|
|---|---|---|---|---|---|---|
|
Norris Medicines
| 26.00 | -1.95 | 29.72 | 71.25 | 58.97 | -19.49 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 436.20 | 7,102.59 | 25.88 | 12.5 | |
| 5,240.00 | 8,727.96 | 36.89 | 43.77 | |
| 681.25 | 6,662.49 | 75.46 | 4.01 | |
| 665.80 | 6,153.24 | 22.83 | 12.68 |
No Review & Analysis are available.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Incorporated
1990
Chairman
--
Managing Director
Vimal Shah
Headquarters
Ankleshwar, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Norris Medicines Ltd stood at ₹ 13 Cr as on 31-Dec-24
The share price of Norris Medicines Ltd is ₹18.94 (BSE) as of 23-Apr-2025 16:01 IST. Norris Medicines Ltd has given a return of 38.15% in the last 1 years.
Norris Medicines Ltd has a market capitalisation of ₹ 16 Cr as on 23-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Norris Medicines Ltd is -1.13 times as on 23-Apr-2025, a 122% discount to its peers’ median range of 5.25 times.
Since, TTM earnings of Norris Medicines Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Norris Medicines Ltd and enter the required number of quantities and click on buy to purchase the shares of Norris Medicines Ltd.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
The promoters of Norris Medicines Ltd are VIMAL D SHAH and NAVSARJAN INVESTMENT & TRADING PVT LTD. They collectively own 33.6 per cent of the total equity. The chairman of the company is
There is no promoter pledging in Norris Medicines Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
8,680
|
|
|
7,005
|
|
|
6,570
|
|
|
6,016
|
| Norris Medicines Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
-8.42
|
|
Net Margin(%)
|
-18.05
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Norris Medicines Ltd was ₹-1 Cr.
₹1.71
(
